Ascentage Pharma Group International ADR (AAPG): Next-Year EPS Estimate 60.92%
As of 2026-06-04, Ascentage Pharma Group International ADR (AAPG) has a next-year EPS growth estimate of 60.92%.
On 2026-06-01, analyst consensus for AAPG's next-year EPS growth shifted from 51.51% to 60.92% — a positive change of 9.41 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 46.69%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 60.92%
- EPS growth this year
- 46.69%
- EPS next quarter (est)
- -$0.51
- Last price
- $18.28
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 60.92% | 46.69% | -$0.51 | $18.28 |
| 2026-06-03 | 60.92% | 46.69% | -$0.58 | $17.87 |
| 2026-06-02 | 60.92% | 46.69% | -$0.58 | $18.45 |
| 2026-06-01 | 60.92% | 46.69% | -$0.58 | $19.08 |
| 2026-05-31 | 51.51% | 48.42% | -$0.58 | $20.01 |
| 2026-05-28 | 51.51% | 48.42% | -$0.58 | $19.88 |
| 2026-05-27 | 51.51% | 48.42% | -$0.58 | $20.90 |
| 2026-05-26 | 51.51% | 48.42% | -$0.58 | $20.13 |
| 2026-05-25 | 51.51% | 48.42% | -$0.58 | $21.01 |
| 2026-05-24 | 51.51% | 48.42% | -$0.58 | $21.01 |
| 2026-05-21 | 51.51% | 48.42% | -$0.58 | $20.66 |
| 2026-05-20 | 51.51% | 48.42% | -$0.58 | $19.78 |
| 2026-05-19 | 51.51% | 48.42% | -$0.58 | $18.99 |
| 2026-05-18 | 51.51% | 48.42% | -$0.58 | $18.56 |
| 2026-05-17 | 51.51% | 48.42% | -$0.58 | $19.50 |
| 2026-05-14 | 51.51% | 48.42% | -$0.58 | $20.18 |
| 2026-05-13 | 51.51% | 48.42% | -$0.58 | $20.96 |
| 2026-05-12 | 51.51% | 48.42% | -$0.58 | $21.16 |
| 2026-05-11 | 51.51% | 48.42% | -$0.58 | $21.66 |
| 2026-05-10 | 51.51% | 48.42% | -$0.58 | $21.50 |
| 2026-05-07 | 51.51% | 48.42% | -$0.58 | $21.70 |
| 2026-05-06 | 51.51% | 48.42% | -$0.58 | $21.57 |
| 2026-05-05 | 51.51% | 48.42% | -$0.58 | $21.90 |
| 2026-05-04 | 51.51% | 48.42% | -$0.58 | $22.02 |
| 2026-05-03 | 51.51% | 48.42% | -$0.58 | $23.34 |
| 2026-04-30 | 51.51% | 48.42% | -$0.58 | $22.88 |
| 2026-04-29 | 51.51% | 48.42% | -$0.58 | $22.48 |
| 2026-04-28 | 51.51% | 48.42% | -$0.58 | $23.00 |
| 2026-04-27 | 51.51% | 48.42% | -$0.58 | $23.37 |
| 2026-04-26 | 51.51% | 48.42% | -$0.58 | $23.95 |
Recent News
- Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual MeetingGlobeNewswire
- Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business UpdatesGlobeNewswire
- Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026GlobeNewswire
- Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026GlobeNewswire
- Ascentage Pharma to Participate in Three Upcoming Investor ConferencesGlobeNewswire
- Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 TargetInsider Monkey
- Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026GlobeNewswire
- Ascentage Pharma Receives Clearance from Chinas CDE for New DrugExec Edge
- Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288GlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ascentage Pharma Group International ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Ascentage Pharma Group International ADR (AAPG) has a next-year EPS growth estimate of 60.92%, based on analyst consensus.
When was the latest EPS estimate revision for AAPG?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 51.51% to 60.92%.
What sector and industry does Ascentage Pharma Group International ADR belong to?▾
Ascentage Pharma Group International ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AAPG appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ascentage Pharma Group International ADR (AAPG) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports